CLINICAL_TRIALS
trial_result
· 2024-03-07
Clinical Trial Update: Montelukast Therapy on Alzheimer's Disease [Phase 2]
Summary
Phase 2 trial of montelukast for Alzheimer's disease has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Emory University | Conditions: Alzheimer Disease | Phase 2 | Status: COMPLETED | Results posted: 2024-03-07